ylaxis. Although a few
included studies evaluated the efﬁcacy of fondaparinux
and rivaroxaban as well as short vs extended courses of
prophylaxis, conclusions based on the available data
are difﬁcult.
A second broader meta-analysis included 47 randomized trials, 105 prospective cohort studies, 67 retrospective cohort studies, and 2 case control studies including
a total of 476, 266 patients